|
English
|
正體中文
|
简体中文
|
2818629
|
|
???header.visitor??? :
28129040
???header.onlineuser??? :
780
???header.sponsordeclaration???
|
|
|
|
???tair.name??? >
???browser.page.title.author???
|
"vogelzang nicholas j"???jsp.browse.items-by-author.description???
Showing items 1-3 of 3 (1 Page(s) Totally)
1
View [10|25|50] records per page
| 國立成功大學 |
2014-04-01 |
An Open-Label, Single-Arm, Phase 2 Trial of the PoloLike Kinase Inhibitor Volasertib ( BI 6727) in Patients With Locally Advanced or Metastatic Urothelial Cancer
|
Stadler, Walter M.; Vaughn, David J.; Sonpavde, Guru; Vogelzang, Nicholas J.; Tagawa, Scott T.; Petrylak, Daniel P.; Rosen, Peter; Lin, Chia-Chi; Mahoney, John; Modi, Sanjiv; Lee, Peter; Ernstoff, Marc S.; Su, Wu-Chou; Spira, Alexander; Pilz, Korinna; Vinisko, Richard; Schloss, Charles; Fritsch, Holger; Zhao, Charles; Carducci, Michael A. |
| 國立臺灣大學 |
2008-04 |
Systemic therapy for metastatic urothelial carcinoma
|
Lin, Chia-Chi; Hsu, Chih-Hung; Pu, Yeong-Shiau; Vogelzang, Nicholas J. |
| 國立臺灣大學 |
2006-03 |
Weekly Cisplatin Plus Infusional High-Dose 5-Fluorouracil and Leucovorin (P-HDFL) for Metastatic Urothelial Carcinoma --- An Effective Regimen with Low Toxicity
|
Lin, Chia-Chi; Hsu, Chih-Hung; Huang, Chao-Yuan; Cheng, Ann-Lii; Chen, Jun; Vogelzang, Nicholas J.; Pu, Yeong-Shiau |
Showing items 1-3 of 3 (1 Page(s) Totally)
1
View [10|25|50] records per page
|
